Back
Relay Therapeutics Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Sell
18
RLAY
Relay Therapeutics
Last Price:
4.70
Seasonality Move:
-6.4%
Sell
20
LXRX
Lexicon Pharmaceuticals
Last Price:
0.80
Seasonality Move:
23.34%
Sell
18
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy, Sell or Hold?
- The current Relay Therapeutics [RLAY] share price is $4.66. The Score for RLAY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $0.81. The Score for LXRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RLAY Stock Price Chart
What is Relay Therapeutics's stock price today?
-
The Relay Therapeutics share price today is $4.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight buying pressure.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.
RLAY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 23.85 | Sell |
| Chaikin Money Flow: | 194739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.35 - 6.45) | Sell |
| Bollinger Bands (100): | (5.96 - 8) | Sell |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 21.81 | Sell |
| Chaikin Money Flow: | -2271611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.89) | Sell |
| Bollinger Bands (100): | (1.38 - 2) | Sell |
RLAY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.37 | Sell |
| 20-day SMA: | 5.73 | Sell |
| 50-day SMA: | 6.5 | Sell |
| 200-day SMA: | 7.36 | Sell |
| 8-day EMA: | 5.22 | Sell |
| 20-day EMA: | 5.69 | Sell |
| 50-day EMA: | 6.26 | Sell |
| 200-day EMA: | 7.52 | Sell |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.02 | Sell |
| 20-day SMA: | 1.35 | Sell |
| 50-day SMA: | 1.56 | Sell |
| 200-day SMA: | 1.87 | Sell |
| 8-day EMA: | 1 | Sell |
| 20-day EMA: | 1.25 | Sell |
| 50-day EMA: | 1.48 | Sell |
| 200-day EMA: | 1.72 | Sell |
Relay Therapeutics Earnings Growth & RLAY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.14 per share.
Relay Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||